Consumer

Dr. Nele Jessel, chief medical officer at Athenahealth, discusses how bringing behavioral health tools, such as telehealth, into the primary care setting can improve access to services and reduce the stigma around mental health conditions.  

The kit was determined to be comparable to a device used in clinically-administered intrauterine insemination.

Dr. Michael Howell, Google's chief clinical officer, discusses what federal regulators should consider while configuring rules around AI use in healthcare and how the company ensures health equity within its medically tuned LLM, Med-PaLM.  

The tech giant revealed it created an LLM optimized for diagnostic reasoning with the ability to generate a differential diagnosis or assist clinicians in coming to a diagnosis.

Execs overwhelmingly cite genAI as having the most significant impact in healthcare this year, though others provide alternative takes on the years' events.

The companies will leverage Absci's AI-enabled Integrated Drug Creation platform and the pharma giant's oncology research and development expertise.

The partners will initially launch in two clinics in Texas to provide patients with ALS access to virtual-first specialty care providers, including respiratory therapists.

Dr. Michael Howell, chief clinical officer at Google, discusses Med-PaLM's evolution in 2023 and recommendations for regulators developing rules for AI use in healthcare.

Researchers will study how Rion’s Purified Exosome Product may aid service members with pulmonary disease via a collaboration with the U.S. Army Medical Research Institute and Mayo Clinic, says Dr. Atta Behfar, Rion’s CEO and cofounder.

An automotive manufacturer in Japan has transformed its speech-to-text mobile app to an audio recognition system to help alleviate barriers in communication.